{"organizations": [], "uuid": "43cdf66adf144bd2c18002640cbeb6787b62c030", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.reuters.com", "main_image": "https://s4.reutersmedia.net/resources_v2/images/rcom-default.png", "site_section": "http://feeds.reuters.com/reuters/companyNews", "section_title": "Reuters: Company News", "url": "https://www.reuters.com/article/brief-adamas-pharmaceuticals-says-as-of/brief-adamas-pharmaceuticals-says-as-of-feb-28-co-received-prescriptions-for-gocovri-from-about-390-distinct-prescribers-idUSFWN1QU0DI", "country": "US", "domain_rank": 408, "title": "BRIEF-Adamas Pharmaceuticals Says ‍As Of Feb 28, Co Received Prescriptions For Gocovri From About 390 Distinct Prescribers", "performance_score": 0, "site": "reuters.com", "participants_count": 0, "title_full": "", "spam_score": 0.0, "site_type": "news", "published": "2018-03-12T12:27:00.000+02:00", "replies_count": 0, "uuid": "43cdf66adf144bd2c18002640cbeb6787b62c030"}, "author": "", "url": "https://www.reuters.com/article/brief-adamas-pharmaceuticals-says-as-of/brief-adamas-pharmaceuticals-says-as-of-feb-28-co-received-prescriptions-for-gocovri-from-about-390-distinct-prescribers-idUSFWN1QU0DI", "ord_in_thread": 0, "title": "BRIEF-Adamas Pharmaceuticals Says ‍As Of Feb 28, Co Received Prescriptions For Gocovri From About 390 Distinct Prescribers", "locations": [], "entities": {"persons": [{"name": "prescrip", "sentiment": "negative"}], "locations": [], "organizations": [{"name": "brief-adamas pharmaceuticals", "sentiment": "negative"}, {"name": "brief-adamas pharmaceuticals says ‍as of feb", "sentiment": "neutral"}, {"name": "sec", "sentiment": "none"}, {"name": "adamas pharmaceuticals inc", "sentiment": "none"}, {"name": "reuters", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": " 30 AM / Updated 6 minutes ago BRIEF-Adamas Pharmaceuticals Says ‍As Of Feb 28, Co Received Prescriptions For Gocovri From About 390 Distinct Prescribers Reuters Staff 1 Min Read March 12 (Reuters) - Adamas Pharmaceuticals Inc: * ADAMAS PHARMACEUTICALS SAYS ‍AS OF FEB 28, CO RECEIVED PRESCRIPTIONS FOR GOCOVRI FROM ABOUT 390 DISTINCT PRESCRIBERS - SEC FILING​ * ADAMAS PHARMACEUTICALS INC - ‍FILLED GOCOVRI PRESCRIPTIONS FOR PERIOD FROM JAN 1, 2018, THROUGH FEB 28, 2018, WERE 742​ Source text: ( bit.ly/2FMaTSW ) Further company coverage:", "external_links": [], "published": "2018-03-12T12:27:00.000+02:00", "crawled": "2018-03-12T12:40:42.006+02:00", "highlightTitle": ""}